home / stock / dnac / dnac news


DNAC News and Press, Social Capital Suvretta Holdings Corp. III From 05/20/22

Stock Information

Company Name: Social Capital Suvretta Holdings Corp. III
Stock Symbol: DNAC
Market: NASDAQ

Menu

DNAC DNAC Quote DNAC Short DNAC News DNAC Articles DNAC Message Board
Get DNAC Alerts

News, Short Squeeze, Breakout and More Instantly...

DNAC - ProKidney to present at upcoming investor conferences

WINSTON-SALEM, N.C., May 20, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the prevention of both end-stage renal disease (ESRD) and the need for dialysis, today announce...

DNAC - ProKidney highlights key registrational program elements supporting advancement of REACT®

WINSTON-SALEM, N.C., May 03, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (CKD) and the prevention of both end-stage renal disease (ESRD) and the need for dialysis, today highligh...

DNAC - ProKidney and Social Capital Suvretta Holdings Corp. III ("SCS") to Host Analyst and Investor Day on April 28, 2022

WINSTON-SALEM, N.C., April 18, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (ProKidney) is a leading Phase 3 clinical-stage cellular therapeutics company with Regenerative Medicine Advanced Therapy (RMAT) Designation that has the goal of delaying chronic kidney disease (CKD), preventing end-stage ...

DNAC - ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT®

WINSTON-SALEM, N.C., April 12, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (“ProKidney”), a leading clinical-stage cellular therapeutics company focused on therapies for chronic kidney disease (“CKD”), today announced the updated design for its REACT ® Phase 3...

DNAC - SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BRLI, DNAA, DNAC, RC

NEW YORK, NY / ACCESSWIRE / March 2 ,2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Brilliant Acquisition Corporation (N...

DNAC - DNAC Stock: 11 Things to Know Ahead of the ProKidney SPAC Merger

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s a new Chamath Palihapitiya special purpose acquisition company (SPAC) coming to the markets soon, and its name is ProKidney . The medical technology company will merge with Social Capital Suvretta Holdings ...

DNAC - SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates SPKB, DNAC, MCAE, ARIZ

NEW YORK, NY / ACCESSWIRE / February 17, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Silver Spike Acquisition Corp. I...

DNAC - ProKidney Announces Online Publication of Trial Design for Phase II Multicenter Clinical Trial of REACT® Autologous Cell Therapy for Treatment of Chronic Kidney Disease

Article published online in American Journal of Nephrology ; to be included in future print edition WINSTON SALEM, N.C., Jan. 27, 2022 (GLOBE NEWSWIRE) -- ProKidney LP (“ProKidney”), a leading clinical-stage cellular therapeutics company focused on chronic kidn...

DNAC - SOFI Stock: 11 Reasons Why Investors Are Banking On a SoFi Bank Charter

InvestorPlace - Stock Market News, Stock Advice & Trading Tips SoFi Technologies (NASDAQ: SOFI ) stock is on the move Tuesday as investors discuss a potential bank charter for the company. Source: rafapress / Shutterstock.com Let’s dive into what a bank charter wou...

DNAC - DNAC Stock Alert: Chamath Palihapitiya's SPAC Preps for ProKidney Merger

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chamath Palihapitiya’s Social Capital Suvretta Holdings III (NASDAQ: DNAC ) announced this morning it is merging with medical technology company ProKidney in a $2.6 billion deal. This move seems to have inves...

Previous 10 Next 10